Dr. Reddy's Laboratories launches Doxycycline Capsules, 40 mg in US
ORACEA is a trademark of Galderma Holdings, S.A.
ORACEA is a trademark of Galderma Holdings, S.A.
The joint venture will help JV Partners combine their strengths and grow their complementary nutraceuticals portfolios
Around 7% of the Indian population suffers from IBS
Vericiguat works on a pathway not currently targeted by existing heart failure treatments
Centhaquine is a resuscitative agent presently indicated for the treatment of hypovolemic shock by DGCI
Versavo is the first Dr. Reddy's biosimilar product to be approved and launched in the UK
He is also inducted as a member of the management council and senior management personnel of the company
The acquisition is done through cash consideration, by way of conversion of SAFE (Simple Agreement for Future Equity) investment of US$ 2 Million to Preferred A-1 Shares
Subscribe To Our Newsletter & Stay Updated